MJFF in the News

MJFF Patient Council member Claudia Revilla provides commentary on an Apple-funded smartwatch study measuring Parkinson’s symptoms and how it could transform patient-clinician communication.

MJFF Co-Founder and Executive Vice Chairman Debi Brooks shares the Foundation’s research progress over 20 years and what lies ahead.

The New York Times covers MJFF Founder and best-selling author Michael J. Fox on how three decades of living with Parkinson’s and recent health setbacks (unrelated to the disease) had him reflecting on the big questions about life, illness and aging.

MJFF has long advocated for the value of telehealth in Parkinson’s care. MJFF’s Senior Vice President of Public Policy Ted Thompson, JD, speaks about the need for Medicare to provide this benefit beyond the COVID-19 pandemic.

With the announcement of a $1-billion biotechnology deal between Biogen and Denali Therapeutics, MJFF’s impact in de-risking LRRK2 therapies is featured within STAT’s coverage of the collaboration.

USA Today covers the Foundation’s announcement of the largest data set of self-reported data on COVID-19 and Parkinson’s disease garnered through our online clinical study, Fox Insight. The story includes an interview with Fox Insight’s principal investigator and professor at the University of California, San Francisco, Carlie Tanner, MD, PhD.

Rachel Dolhun, MD, vice president of medical communications at MJFF, provides expert commentary on the impact of delayed drugs for the Parkinson’s community during the COVID-19 pandemic.

MJFF’s Vice President of Medical Communications Rachel Dolhun, MD and other neurological disease experts discuss learnings from the pandemic as society prepares to reopen.